1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
The Sloan Foundation's exploratory grantmaking in Technology supports the development and adoption of AI tools that accelerate scientific research and automate aspects of the scientific process.
Funded scope includes foundation models for science (chemistry, biology, materials, physics), AI lab automation and self-driving laboratories, AI-driven literature review and synthesis tools, machine learning for experimental design, scientific reasoning and hypothesis generation in LLMs, and infrastructure for open scientific AI.
The exploratory program identifies emerging sectors, tools, and methods with high potential that may not yet attract mainstream funding, prioritizing interdisciplinary risk-taking work.
Get alerted about grants like this
Get emailed when new opportunities from “Alfred P. Sloan Foundation” or related funders appear. Free, weekly, unsubscribe anytime.
Or search similar grants →According to the current listing, eligibility includes: U.S. and international non-profit research institutions, universities, and individual investigators. Open to all career stages. Rolling letter of inquiry process; invited full proposals follow. Strong fit for projects building AI infrastructure or methodology with broad applicability across scientific domains. Confirm the full requirements in the official notice before applying.
The current listing shows grants typically range from $100,000 to $400,000 per project. Rolling letters of inquiry accepted year-round. Verify award ceilings, matching requirements, and allowable costs in the official notice.
Applications for Sloan Foundation Exploratory Grantmaking in Technology for AI in Science and Research Automation 2026 are due December 31, 2026. Build your timeline backwards from this date to cover registrations, approvals, and final submission checks.
Sloan Foundation Exploratory Grantmaking in Technology for AI in Science and Research Automation 2026 is funded by Alfred P. Sloan Foundation. Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
Science on Screen is sponsored by Coolidge Corner Theatre Foundation (with support from the Alfred P. Sloan Foundation). This grant initiative brings science to cinemas nationwide by supporting creative pairings of current, classic, cult, and documentary films with lively introductions by notable figures from the world of science, technology, and medicine.
Sundance Institute Episodic Program (Alfred P. Sloan Foundation Grant) is sponsored by Sundance Institute (funded by Alfred P. Sloan Foundation). This program is for emerging to mid-career writers and creators across all scripted series platforms. One project will be selected from submissions and awarded a separate monetary grant provided by the Alfred P.
The John Templeton Foundation's 2026 Online Funding Inquiry (OFI) cycle prioritizes projects exploring intelligences across natural, human, and artificial systems. Funded AI-relevant scope includes the science of intelligence and cognition, philosophical and ethical foundations of AI, comparative intelligence research (human, animal, machine), human flourishing in an AI-mediated world, foundations of trust and value alignment, and AI's implications for meaning, agency, virtue, and religious traditions. Two competitive OFI cycles per year; successful inquiries are invited to submit full proposals.
The ADDF-Harrington Scholar Program identifies and accelerates promising drug discovery research for Alzheimer's disease and related dementias, with explicit support for AI/ML-enabled approaches including generative AI for novel drug candidate identification, deep learning for target validation, AI-driven repurposing of approved drugs, and computational platforms for amyloid and tau pathology. Scholars receive a 2-year grant of $600K plus comprehensive drug development expertise from the Harrington Discovery Institute and ADDF's Drug Development Accelerator. Optional follow-on investment through ADDF's venture arm. Strong fit for academic investigators with promising preclinical leads, AI-enabled drug discovery platforms, or novel computational therapeutic approaches.